Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels

  • C. Matthias Wilk
  • , Larisa V. Kovtonyuk
  • , Markus G. Manz

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science